Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
- DOI
- 10.1002/ijc.31400
- Published
- 2018-04-16
- Container
- International Journal of Cancer
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ijc.31400,
title = {Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer},
author = {Yang Ge and Nathaniel Weygant and Dongfeng Qu and Randal May and William L. Berry and Jiannan Yao and Parthasarathy Chandrakesan and Wei Zheng and Lichao Zhao and Karena L. Zhao and Michael Drake and Kenneth J. Vega and Michael S. Bronze and James J. Tomasek and Guangyu An and Courtney W. Houchen},
year = {2018},
journal = {International Journal of Cancer},
doi = {10.1002/ijc.31400},
url = {https://doi.org/10.1002/ijc.31400}
}RIS
TY - JOUR TI - Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer AU - Yang Ge AU - Nathaniel Weygant AU - Dongfeng Qu AU - Randal May AU - William L. Berry AU - Jiannan Yao AU - Parthasarathy Chandrakesan AU - Wei Zheng AU - Lichao Zhao AU - Karena L. Zhao AU - Michael Drake AU - Kenneth J. Vega AU - Michael S. Bronze AU - James J. Tomasek AU - Guangyu An AU - Courtney W. Houchen PY - 2018 JO - International Journal of Cancer DO - 10.1002/ijc.31400 UR - https://doi.org/10.1002/ijc.31400 ER -
APA
Ge, Y., Weygant, N., Qu, D., May, R., Berry, W. L., Yao, J., Chandrakesan, P., Zheng, W., Zhao, L., Zhao, K. L., Drake, M., Vega, K. J., Bronze, M. S., Tomasek, J. J., An, G., & Houchen, C. W. (2018). Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.31400
Source records
- crossref · retrieved 2026-09-26T17:27:54.463Z